REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/17/2026
Back to search
Official data from USPTO
PERSERIS PATIENT INJECTION NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
08/17/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
10/02/2020
Registration date
08/17/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2021
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/27/2019
First use in commerce
02/27/2019
Drawing code
3
Owner type
99
Owner location
Hull, GB
Examiner
KHOURI, SANI PHILIPPE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a location tag design with an incomplete circle above a triangle over the words "PERSERIS PATIENT INJECTION NETWORK".
Holders and representatives
Holders
Indivior UK Limited
Representatives
Shauna M. Wertheim The Marbury Law Group, PLLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing an interactive web site featuring technology that enables users to searchlocate and access health care and medical service providers; providing an interactive web site featuring technology that enables users to searchlocate and access injection administration service providers
Class 44
Provision of health care information and advice; Provision of pharmaceutical information and advice for medical purposes; provision of health care information and advice relating to administration of pharmaceutical injectables
Publications
History of USPTO decisions and trademark events.
39 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/20/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/18/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/18/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/18/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/18/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/18/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/18/2023
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
08/31/2023
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
08/31/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/30/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/30/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/30/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/17/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/01/2021
PUBO
PUBLISHED FOR OPPOSITION
06/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/28/2021
ALIE
ASSIGNED TO LIE
04/27/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/27/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/27/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/27/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/23/2021
GNRT
NON-FINAL ACTION E-MAILED
04/23/2021
CNRT
NON-FINAL ACTION WRITTEN
04/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/17/2021
GNRT
NON-FINAL ACTION E-MAILED
02/17/2021
CNRT
NON-FINAL ACTION WRITTEN
02/17/2021
DOCK
ASSIGNED TO EXAMINER
02/12/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/18/2020
NWAP
NEW APPLICATION ENTERED
10/06/2020
Continuous trademark protection
Get notified about every new filing that threatens PERSERIS PATIENT INJECTION NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.